Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

In-Jin Jang

Showing results (1-10 of 292) with videos related to

Pageof 30
Sort By:
Scientific Reports|December 9, 2022
Evaluation of drug prescribing patterns and therapeutic drug monitoring practice using electronic medical recordsSangmi Lee, Seonghae Yoon, In-Jin Jang
Anesthesia and Analgesia|November 29, 2002
A comparison of ketamine and lidocaine spray with propofol for the insertion of laryngeal mask airway in children: a double-blinded randomized trialJae-Hyon Bahk, Joohon Sung, In-Jin Jang
Drug Design, Development and Therapy|August 9, 2018
Pharmacokinetic interaction between fimasartan and atorvastatin in healthy male volunteersYewon Choi, SeungHwan Lee, In-Jin Jang, et al.
Clinical Pharmacokinetics|March 10, 2023
Evaluation of CYP2C19-Mediated Pharmacokinetic Drug Interaction of Tegoprazan, Compared with Vonoprazan or EsomeprazoleEunsol Yang, Sang Chun Ji, In-Jin Jang, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 4, 2025
Model-Informed Precision Dosing of Infliximab in Korean Inflammatory Bowel Disease Patients: External Validation of Population Pharmacokinetic ModelsYoonjin Kim, Seung Hwan Baek, In-Jin Jang, et al.
Clinical and Translational Science|October 19, 2021
Pharmacokinetics and safety of a novel influenza treatment (baloxavir marboxil) in Korean subjects compared with Japanese subjectsYun Kim, Sangwon Lee, Yohan Kim, et al.
Translational and Clinical Pharmacology|July 8, 2026
Pharmacokinetics and safety of nafamostat and its metabolites following single- and multiple-dose oral administration of nafamostat mesylate in healthy male participantsJun Ki Hong, Hyun Chul Kim, In-Jin Jang, et al.
Translational and Clinical Pharmacology|January 10, 2024
Adaptive design clinical trials: current status by disease and trial phase in various perspectivesHyunjoon Lee, Sejung Hwang, In-Jin Jang, et al.
Drug Design, Development and Therapy|February 25, 2021
Pharmacokinetic and Pharmacodynamic Comparison of Two Formulations of a Fixed-Dose Combination of Gemigliptin/Rosuvastatin 50/20 mg: A Randomized, Open-Label, Single-Dose, Two-Way Crossover StudyEunsol Yang, Hyounggyoon Yoo, In-Jin Jang, et al.
Drug Design, Development and Therapy|September 11, 2015
Pharmacokinetics, pharmacodynamics, and tolerability of LC350189, a novel xanthine oxidase inhibitor, in healthy subjectsSeonghae Yoon, Donghoon Shin, Howard Lee, et al.
Pageof 30

Showing results (1-10 of 292) with videos related to

Sort By:
Pageof 30
Scientific Reports|December 9, 2022
Evaluation of drug prescribing patterns and therapeutic drug monitoring practice using electronic medical recordsSangmi Lee, Seonghae Yoon, In-Jin Jang
Anesthesia and Analgesia|November 29, 2002
A comparison of ketamine and lidocaine spray with propofol for the insertion of laryngeal mask airway in children: a double-blinded randomized trialJae-Hyon Bahk, Joohon Sung, In-Jin Jang
Drug Design, Development and Therapy|August 9, 2018
Pharmacokinetic interaction between fimasartan and atorvastatin in healthy male volunteersYewon Choi, SeungHwan Lee, In-Jin Jang, et al.
Clinical Pharmacokinetics|March 10, 2023
Evaluation of CYP2C19-Mediated Pharmacokinetic Drug Interaction of Tegoprazan, Compared with Vonoprazan or EsomeprazoleEunsol Yang, Sang Chun Ji, In-Jin Jang, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 4, 2025
Model-Informed Precision Dosing of Infliximab in Korean Inflammatory Bowel Disease Patients: External Validation of Population Pharmacokinetic ModelsYoonjin Kim, Seung Hwan Baek, In-Jin Jang, et al.
Clinical and Translational Science|October 19, 2021
Pharmacokinetics and safety of a novel influenza treatment (baloxavir marboxil) in Korean subjects compared with Japanese subjectsYun Kim, Sangwon Lee, Yohan Kim, et al.
Translational and Clinical Pharmacology|July 8, 2026
Pharmacokinetics and safety of nafamostat and its metabolites following single- and multiple-dose oral administration of nafamostat mesylate in healthy male participantsJun Ki Hong, Hyun Chul Kim, In-Jin Jang, et al.
Translational and Clinical Pharmacology|January 10, 2024
Adaptive design clinical trials: current status by disease and trial phase in various perspectivesHyunjoon Lee, Sejung Hwang, In-Jin Jang, et al.
Drug Design, Development and Therapy|February 25, 2021
Pharmacokinetic and Pharmacodynamic Comparison of Two Formulations of a Fixed-Dose Combination of Gemigliptin/Rosuvastatin 50/20 mg: A Randomized, Open-Label, Single-Dose, Two-Way Crossover StudyEunsol Yang, Hyounggyoon Yoo, In-Jin Jang, et al.
Drug Design, Development and Therapy|September 11, 2015
Pharmacokinetics, pharmacodynamics, and tolerability of LC350189, a novel xanthine oxidase inhibitor, in healthy subjectsSeonghae Yoon, Donghoon Shin, Howard Lee, et al.
Pageof 30